A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin
Journal of the American Chemical Society2014Vol. 136(16), pp. 5896–5899
Citations Over TimeTop 1% of 2014 papers
Longyan Liao, Jenny Liu, Erik C. Dreaden, Stephen W. Morton, Kevin E. Shopsowitz, Paula T. Hammond, Jeremiah A. Johnson
Abstract
The synthesis of polymer therapeutics capable of controlled loading and synchronized release of multiple therapeutic agents remains a formidable challenge in drug delivery and synthetic polymer chemistry. Herein, we report the synthesis of polymer nanoparticles (NPs) that carry precise molar ratios of doxorubicin, camptothecin, and cisplatin. To our knowledge, this work provides the first example of orthogonally triggered release of three drugs from single NPs. The highly convergent synthetic approach opens the door to new NP-based combination therapies for cancer.
Related Papers
- → Experimental and theoretical investigation of the molecular and electronic structure of anticancer drug camptothecin(2010)44 cited
- → Effect of precursors feeding and media manipulation on production of novel anticancer pro-drug camptothecin from endophytic fungus.(2012)24 cited
- Distribution of anticancer drug in Ophiorrhiza japonica(2009)
- The Progress of Research and Application of Anticancer Drug 10-Hydroxy Camptothecin(2007)